BioScrip Inc.

9.94+0.0100+0.10%Vol 100.10K1Y Perf -
Jun 28th, 2022 00:54 DELAYED
BID9.91 ASK10.05
Open9.94 Previous Close9.93
Pre-Market- After-Market-
 - -  - -%
Target Price
4.42 
Analyst Rating
— — 0.00
Potential %
-55.53 
Finscreener Ranking
★+ —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★★+     60.74
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★     46.22
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
76.19 
Earnings Rating
Buy
Market Cap291.34M 
Earnings Date
20th Mar 2020
Alpha-0.00 Standard Deviation0.01
Beta-0.04 

Today's Price Range

9.949.94

52W Range

9.789.99

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
0.10%
1 Month
0.40%
3 Months
0.61%
6 Months
-
1 Year
-
3 Years
297.60%
5 Years
266.79%
10 Years
31.48%

TickerPriceChg.Chg.%
BIOS9.940.01000.10
AAPL138.932.21001.62
GOOG2 181.62-5.8300-0.27
MSFT259.582.75001.07
XOM87.551.91002.23
WFC39.920.75001.91
JNJ179.522.01001.13
FB196.640.99000.51
GE63.54-0.1300-0.20
JPM114.051.44001.28
Earnings HistoryEstimateReportedSurprise %
Q03 2019-0.01-0.010.00
Q02 2019-0.10-0.13-30.00
Q01 2019-0.12-0.1016.67
Q04 2018-0.03-0.14-366.67
Q03 2018-0.07-0.09-28.57
Q02 2018-0.10-0.14-40.00
Q01 2018-0.11-0.12-9.09
Q04 2017-0.08-0.15-87.50
Earnings Per EndEstimateRevision %Trend
12/2019 QR0.00-100.00Negative
12/2019 FY-0.21-16.67Negative
3/2020 QR-0.01-200.00Negative
12/2020 FY0.00-100.00Negative
Next Report Date-
Estimated EPS Next Report-
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume100.10K
Shares Outstanding29.31K
Shares Float22.68M
Trades Count3
Dollar Volume995.00K
Avg. Volume66.95K
Avg. Weekly Volume125.10K
Avg. Monthly Volume24.55K
Avg. Quarterly Volume51.20K

BioScrip Inc. (NASDAQ: BIOS) stock closed at 9.94 per share at the end of the most recent trading day (a 0.1% change compared to the prior day closing price) with a volume of 100.10K shares and market capitalization of 291.34M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 2043 people. BioScrip Inc. CEO is John Charles Rademacher.

The one-year performance of BioScrip Inc. stock is %, while year-to-date (YTD) performance is 137.8%. BIOS stock has a five-year performance of 266.79%. Its 52-week range is between 9.78 and 9.99, which gives BIOS stock a 52-week price range ratio of 76.19%

BioScrip Inc. currently has a PE ratio of -352.10, a price-to-book (PB) ratio of 2.95, a price-to-sale (PS) ratio of 1.91, a price to cashflow ratio of 110.70, a PEG ratio of 2.32, a ROA of -0.34%, a ROC of -0.14% and a ROE of -0.36%. The company’s profit margin is -3.87%, its EBITDA margin is 2.00%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from BioScrip Inc., there were 1 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. BioScrip Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for BioScrip Inc. is (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for BioScrip Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

BioScrip Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

BioScrip Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 10.22, ATR14 : 0.03, CCI20 : 56.76, Chaikin Money Flow : -0.62, MACD : 0.09, Money Flow Index : 24.79, ROC : 0.51, RSI : 52.54, STOCH (14,3) : 62.50, STOCH RSI : 0.30, UO : 52.05, Williams %R : -37.50), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of BioScrip Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (100.00 %)
2 (100.00 %)
3 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary Rating-
0.00
-
0.00
-
0.00

BioScrip Inc.

Option Care Health Inc formerly known as BioScrip Inc is one of the provider of home infusion services and home care management solutions in the United States. The firm's home infusion services primarily involve the intravenous administration of medications treating a wide range of acute and chronic conditions, such as infections, nutritional deficiencies, various immunologic and neurologic disorders, cancer, pain and palliative care. It provides a wide array of home infusion products and services to meet the diverse needs of physicians, patients, and payors.

CEO: John Charles Rademacher

Telephone: +1 312 940-2443

Address: 3000 Lakeside Dr., Bannockburn 60015, IL, USA

Number of employees: 2 043

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

58%42%

Bearish Bullish

49%51%

News

Stocktwits